Neoplasms, Connective and Soft Tissue  >>  gemcitabine  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gemcitabine / Generic mfg.
NCT00614835: Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

Completed
N/A
25
US
Docetaxel plus Gemcitabine
Memorial Sloan Kettering Cancer Center
Uterine Leiomyosarcoma, Uterine Cancer
02/06
01/12
NCT00673179: Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

Terminated
N/A
7
US
Doxorubicin, AD, Hydroxydaunomycin hydrochloride, Cisplatin, Paraplatin®, Methotrexate, Leucovorin, Dexrazoxane, Zinecard, Ifosfamide, Ifex, Questionnaire, Survey, Gemcitabine, Gemzar, Gemcitabine Hydrochloride, Sargramostim, GM-CSF, Leukine™, Surgery, Mesna, Mesnex
M.D. Anderson Cancer Center
Osteosarcoma
11/10
11/10

Download Options